4//SEC Filing
KASINGER JAMES R. 4
Accession 0000950170-25-038215
CIK 0001674416other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 7:05 PM ET
Size
14.0 KB
Accession
0000950170-25-038215
Insider Transaction Report
Form 4
KASINGER JAMES R.
General Counsel and Secretary
Transactions
- Sale
Common Shares
2025-03-11$42.42/sh−2,850$120,897→ 77,530 total - Exercise/Conversion
Common Shares
2025-03-10+5,500→ 80,380 total - Exercise/Conversion
Common Shares
2025-03-11+2,250→ 79,780 total - Sale
Common Shares
2025-03-12$43.32/sh−1,116$48,345→ 78,664 total - Exercise/Conversion
Restricted Stock Units
2025-03-10−5,500→ 11,000 total→ Common Shares (5,500 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-11−2,250→ 0 total→ Common Shares (2,250 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
- [F3]This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.
- [F4]This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001708172
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 7:05 PM ET
- Size
- 14.0 KB